Company Filing History:
Years Active: 2022
Title: Pawan Kalani: Innovator in Bioconjugate Technology
Introduction
Pawan Kalani is a notable inventor based in Jodhpur, India. He has made significant contributions to the field of biotechnology, particularly in the detection of neutralizing antibodies against recombinant human insulin. His work is crucial for advancing diabetes treatment and monitoring.
Latest Patents
Pawan Kalani holds a patent for a method titled "Method for detecting neutralizing antibodies against recombinant human insulin in human serum." This invention provides an in vitro method for detecting the presence of neutralizing antibodies against recombinant human insulin (rHI) in human serum. Additionally, it includes a kit designed for the in vitro detection of these antibodies, which is essential for ensuring the efficacy of insulin therapies.
Career Highlights
Kalani is currently employed at Biocon Limited, a leading biopharmaceutical company known for its innovative solutions in healthcare. His role at Biocon has allowed him to work on cutting-edge research and development projects that aim to improve patient outcomes.
Collaborations
Some of his coworkers include Abhishek Kulshrestha and Ravi Shankar Maurya, who collaborate with him on various projects within the company.
Conclusion
Pawan Kalani's contributions to biotechnology, particularly through his patent on detecting neutralizing antibodies, highlight his role as an innovator in the field. His work at Biocon Limited continues to impact the healthcare industry positively.